When Medicine Becomes the Problem
Americans fill approximately 4.7 billion prescriptions per year. The vast majority of medications are safe when used as directed. But history has shown repeatedly that some drugs reach the market with undisclosed or underestimated risks — causing serious injuries, chronic conditions, and even death.
Major pharmaceutical litigation has included: Vioxx (rofecoxib) — withdrawn after studies linked it to increased heart attack and stroke risk. Merck ultimately paid $4.85 billion to settle approximately 27,000 claims. Zantac (ranitidine) — pulled from the market after studies showed it could break down into NDMA, a probable human carcinogen. Opioids (OxyContin, etc.) — manufacturers and distributors face billions in liability for fueling the opioid epidemic through deceptive marketing. Xarelto and Eliquis — blood thinners linked to uncontrollable bleeding events.
Legal Theories in Dangerous Drug Cases
Drug injury claims typically involve: Failure to warn: The most common theory. The manufacturer knew about side effects but failed to include adequate warnings on the drug's label or in its prescribing information for doctors. Defective design: The drug is inherently dangerous — its risks outweigh its benefits for the indicated population. This is harder to prove because all drugs have some side effects. Defective manufacturing: The specific batch of medication was contaminated, improperly formulated, or otherwise deviated from the intended composition. Fraud and misrepresentation: The manufacturer misrepresented clinical trial data, downplayed adverse events, or engaged in off-label marketing.
The 'Learned Intermediary' Doctrine
In most states, drug manufacturers' duty to warn runs to the prescribing physician — not directly to the patient. Under the 'learned intermediary' doctrine, manufacturers fulfill their warning obligation by providing adequate information to doctors, who then use their medical judgment to decide whether to prescribe the drug. However, this doctrine has important exceptions: Direct-to-consumer advertising (DTC ads) — when manufacturers market directly to consumers, some courts hold they have a direct duty to warn patients. Vaccines — handled under the National Childhood Vaccine Injury Act. Over-the-counter drugs — manufacturers must warn consumers directly since no physician intermediary exists.
Class Actions vs. Mass Torts
Drug injury cases are typically handled as mass torts rather than class actions. In a class action, one outcome applies to all members. In a mass tort, each plaintiff's case is individually evaluated based on their specific injuries, medical history, and drug usage. Mass tort cases are often consolidated into MDL (Multidistrict Litigation) for pretrial proceedings, then individual cases go to trial or settle based on their unique facts.
Steps to Take If You Suspect a Drug Injury
Do not stop taking any medication without consulting your doctor. Document your symptoms and when they started. Preserve the medication packaging and pharmacy records. Report the adverse event to the FDA's MedWatch program. Request your complete medical records. Contact Bond Legal at (866) 423-7724 for a free case evaluation — we handle dangerous drug cases nationwide on a contingency fee basis.
